7 Treatment Guidelines for Knee and Hip Replacement Surgery
In this slideshow, we highlight newly released treatment recommendations for rheumatic disease patients undergoing total hip or total knee arthroplasty.
New Antirheumatic Drug Guidelines for Hip and Knee Arthroplasty
Rheumatic patients are more prone to complications post knee and hip surgery. Two physician associations have penned new treatment guidelines.
Biosimilar Proves to be OK for Switching
Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.
Here’s What You Should Know about Axial Spondyloarthritis
Chronic back pain, arthritis and enthesitis are among common axSpA manifestations, but no two patients are alike. Here, we highlight key presentations.
Axial Spondyloarthritis Guidelines Updated and Simplified
EULAR-ASAS have updated the 2010 guidelines for axSpA emphasizing treat to target, tapering and for the first time, cost considerations.
Axial Spondyloarthritis Treatment Recommendations
In this slideshow, we highlight the 13 ASAS-EULAR treatment management guidelines for axial spondyloarthritis.
Psoriatic Spondyloarthritis Burden is Similar to Ankylosing Spondylitis
Psoriatic spondyloarthritis forms part of the spondyloarthritis spectrum, between peripheral-only psoriatic arthritis and ankylosing spondylitis.
Adalimumab-atto: It’s Indications and Key Takeaways
In this slideshow, we summarize the newly approved indications for Amgen's new biosimilar, adalimumab-atto (Amjevita) and, we highlight key points as stated by Amgen researchers.
By clicking Accept, you agree to become a member of the UBM Medica Community.